PEDRO PIEDRA to Respiratory Syncytial Viruses
This is a "connection" page, showing publications PEDRO PIEDRA has written about Respiratory Syncytial Viruses.
Connection Strength
4.279
-
Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol. 2019; 10:706.
Score: 0.586
-
Respiratory Syncytial Virus (RSV): Neutralizing Antibody, a Correlate of Immune Protection. Methods Mol Biol. 2016; 1442:77-91.
Score: 0.468
-
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. J Infect Dis. 2016 Feb 01; 213(3):411-22.
Score: 0.455
-
Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):700-6.
Score: 0.369
-
Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007 May 15; 195(10):1532-40.
Score: 0.256
-
Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 May 22; 56:127183.
Score: 0.223
-
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med. 2021 01; 9(1):21-32.
Score: 0.163
-
Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study. Pediatr Allergy Immunol. 2020 10; 31(7):755-766.
Score: 0.159
-
Association of respiratory viruses with serum metabolome in infants with severe bronchiolitis. Pediatr Allergy Immunol. 2019 12; 30(8):848-851.
Score: 0.150
-
RSV Strains and Disease Severity. J Infect Dis. 2019 01 29; 219(4):514-516.
Score: 0.145
-
Respiratory Syncytial Virus and Rhinovirus Bronchiolitis Are Associated With Distinct Metabolic Pathways. J Infect Dis. 2018 03 13; 217(7):1160-1169.
Score: 0.136
-
Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Pediatr Infect Dis J. 1998 Mar; 17(3):217-24.
Score: 0.136
-
Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015 Nov 25; 8:718.
Score: 0.116
-
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection. Antimicrob Agents Chemother. 2016 01; 60(1):6-13.
Score: 0.115
-
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study. J Med Chem. 2015 Feb 26; 58(4):1630-43.
Score: 0.110
-
Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):829-34.
Score: 0.106
-
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5992-7.
Score: 0.104
-
Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus. Vaccine. 1989 Feb; 7(1):34-8.
Score: 0.072
-
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
Score: 0.049
-
Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med. 2001 Feb; 163(2):532-9.
Score: 0.042
-
Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar; 103(3):619-26.
Score: 0.036
-
Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. Clin Infect Dis. 2017 Sep 15; 65(6):967-975.
Score: 0.033
-
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. J Virol. 2016 08 15; 90(16):7508-7518.
Score: 0.030
-
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. Clin Diagn Lab Immunol. 1996 Jul; 3(4):477-9.
Score: 0.030
-
Children Hospitalized with Rhinovirus Bronchiolitis Have Asthma-Like?Characteristics. J Pediatr. 2016 05; 172:202-204.e1.
Score: 0.029
-
Absence of Bordetella pertussis Among Infants Hospitalized for Bronchiolitis in Finland, 2008-2010. Pediatr Infect Dis J. 2016 Feb; 35(2):219-21.
Score: 0.029
-
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
Score: 0.029
-
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995 Sep; 16(3):393-9.
Score: 0.029
-
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis. 1994 Jun; 169(6):1368-73.
Score: 0.026
-
Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease. J Gen Virol. 1989 Feb; 70 ( Pt 2):325-33.
Score: 0.018
-
Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol. 1996 Jul; 34(7):1649-53.
Score: 0.008
-
High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1994 Oct; 125(4):635-41.
Score: 0.007
-
High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr. 1990 Aug; 117(2 Pt 1):313-20.
Score: 0.005
-
Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens. Proc Soc Exp Biol Med. 1988 Jun; 188(2):191-7.
Score: 0.004
-
Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. Int Arch Allergy Appl Immunol. 1988; 86(1):112-6.
Score: 0.004